XORTX Therapeutics Inc.

What they do

XORTX Therapeutics is a pharmaceutical preparations company (SIC 20549) incorporated in British Columbia, Canada. Its principal executive offices are located at 3710 — 33rd Street NW, Calgary, Alberta, Canada. The company reports as a foreign private issuer filing annual reports on Form 20-F. It prepares consolidated financial statements under IFRS as issued by the IASB, with the U.S. dollar as its functional currency effective January 1, 2023.

Recent performance

The company filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 on March 20, 2026. As of the close of that period, 6,962,218 common shares were outstanding. The provided excerpt does not include revenue, expense, or net income figures for the year. Accordingly, no financial performance figures can be reported from this source.

Strategy

The company is an emerging growth company under the JOBS Act and has elected to comply with certain reduced U.S. public company reporting requirements. It reports under IFRS and uses the U.S. dollar as its functional currency. The filing notes that the company may refer to non-IFRS measures, including key performance indicators used by management, as additional information. The provided excerpt does not describe specific product candidates, pipeline programs, or capital allocation priorities.

Risks

• Foreign private issuer and emerging growth company status — As a foreign private issuer and emerging growth company, the company operates under reduced U.S. public company reporting requirements, which may result in less information being available to investors.
• IFRS reporting and non-IFRS measures — Financial statements are prepared under IFRS, and any non-IFRS measures used by management are not standardized and may not be comparable to similar measures presented by other companies.
• Use of unverified market and industry data — The filing states that market and industry data may come from internal research, management estimates, and third-party public information that has not been independently verified.
• Forward-looking statements uncertainty — The annual report contains forward-looking statements that are subject to risks and uncertainties, including those described under the company's risk factors.

Outlook

The provided excerpt states that forward-looking statements relate to future events or the company's future performance. The excerpt does not include specific guidance on product development, regulatory milestones, or financial expectations. No outlook figures or timelines are available from this source.